Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 41, pages 797–804 (2008)Cite this article

Abstract

Our purpose was to determine the prevalence and features of metabolic syndrome (MS) in a series of long-term hematopoietic stem cell transplantation (HSCT) survivors. We assessed the clinical, metabolic and endocrinological data, and plasma TNF, leptin, resistin and adiponectin levels relating to 85 HSCT recipients. MS was diagnosed on the basis of the National Cholesterol Education Program-Adult Treatment Panel III criteria. Its prevalence was compared with that observed in an Italian population, and its relationship with the clinical and laboratory parameters was assessed univariately and multivariately. Twenty-nine HSCT recipients had MS instead of the 12.8 expected (P<0.0001), with hypertriglyceridemia being the most common feature. Univariate analysis indicated that high insulin and leptin levels, low-adiponectin levels and hypogonadism were significantly related to a diagnosis of MS; multivariate analysis indicated plasma leptin, insulin resistance, age and hypogonadism. We conclude that HSCT recipients are at increased risk of a form of MS that has particular clinical features. Plasma leptin levels are independently related to MS, thus suggesting that leptin resistance may play a role as a pathogenetic clue, as in other conditions in which MS occurs as a secondary phenomenon. MS deserves consideration as a life-threatening complication in patients who are probably cured of their underlying disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C, National Heart, Lung and Blood Institute et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 551–556.

    Article  PubMed  Google Scholar 

  2. Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415–1428.

    Article  CAS  PubMed  Google Scholar 

  3. Kahn R, Buse J, Ferrannini E, American Diabetes Association, European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–2304.

    Article  PubMed  Google Scholar 

  4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.

    Article  Google Scholar 

  5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  PubMed  Google Scholar 

  6. Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.

    Article  CAS  PubMed  Google Scholar 

  7. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS . Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006; 55: 1293–1301.

    Article  CAS  PubMed  Google Scholar 

  8. Ridker PM, Buring JE, Cook NR, Rifai N . C-reactive protein, the metabolic syndrome, and the risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391–397.

    Article  PubMed  Google Scholar 

  9. Alessi MC, Juhan Vague I . PAI-1 and the metabolic syndrome: links, causes, and consequences. Atheroscler Thromb Vasc Biol 2006; 26: 2007–2200.

    Article  Google Scholar 

  10. Grinspoon SK . Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med 2005; 118 (Suppl): S23–S28.

    Google Scholar 

  11. Jerico C, Knobel H, Montero M, Ordonez-Llanos J, Guelar JL, Saballs P et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005; 28: 132–137.

    Article  PubMed  Google Scholar 

  12. Munoz SJ . Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: pathogenesis, diagnosis and management. Liver Transpl Surg 1995; 1 (Suppl 1): S29–S38.

    Google Scholar 

  13. de Vries AP, Bakker SJ, van Son WJ, van der Heide JJ, Ploeg RJ, The HT et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004; 4: 1675–1683.

    Article  PubMed  Google Scholar 

  14. Fazelzadeh A, Mehdizadeh A, Ostovan MA, Raiss-Jalali GA . Incidence of cardiovascular risk factors and complications before and after kidney transplantation. Transplant Proc 2006; 38: 506–508.

    Article  CAS  PubMed  Google Scholar 

  15. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lysanen-Nyman M . Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000; 356: 993–997.

    Article  CAS  PubMed  Google Scholar 

  16. Shalitin S, Phillip M, Stein J, Goshen Y, Carmi D, Yaniv I . Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 2006; 37: 1109–1117.

    Article  CAS  PubMed  Google Scholar 

  17. Higgins K, Noon C, Cartwright V . Features of the metabolic syndrome present in survivors of bone marrow transplantation in adulthood. Bone Marrow Transplant 2004; 33 (Suppl 1): S216–S217.

    Google Scholar 

  18. Chatterjee R, Palla K, McGarrigle HH, Mackinnon S, Kottaridis PD . ‘Syndrome X’ in adult female recipients of bone marrow transplantation from haematological malignancies. Bone Marrow Transplant 2005; 35: 209–210.

    Article  CAS  PubMed  Google Scholar 

  19. Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 2007; 109: 1765–1772.

    Article  CAS  PubMed  Google Scholar 

  20. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP . Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005; 54: 333–339.

    Article  CAS  PubMed  Google Scholar 

  21. Miccoli R, Bianchi C, Odoguardi L, Penno G, Caricato F, Giovannetti MG et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis 2005; 15: 250–254.

    Article  PubMed  Google Scholar 

  22. Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA . The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 2002; 28: 195–214.

    Article  CAS  PubMed  Google Scholar 

  23. Nuver J, Smit AJ, Sleijfer DT, van Gessel AI, van Roon AM, van der Meer J et al. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer 2004; 40: 701–706.

    Article  CAS  PubMed  Google Scholar 

  24. Nuver J, Smit AJ, Wolffenbuttel BH, Sluiter WJ, Hoekstra HJ, Sleijfer DT et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005; 23: 3718–3725.

    Article  CAS  PubMed  Google Scholar 

  25. Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK 506). Liver Transpl Surg 1997; 3: 1–9.

    Article  CAS  PubMed  Google Scholar 

  26. Marchetti P . New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transpl 2005; 11: 612–620.

    Article  PubMed  Google Scholar 

  27. Lopez-Miranda J, Perez-Jimenez F, Torres A, Espino-Montoro A, Gomez P, Hidalgo-Rojas L et al. Effect of cyclosporine on plasma lipoproteins in bone marrow transplantation patients. Clin Biochem 1992; 25: 379–386.

    Article  CAS  PubMed  Google Scholar 

  28. Ford ES, Giles WH, Dietz W . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.

    Article  PubMed  Google Scholar 

  29. Park YW, Zhu S, Palaniappan L, Heshka C, Carnethon MR, Heymsfield SB . The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003; 163: 427–436.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ford ES, Giles WH, Mokdad AH . Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444–2449.

    Article  PubMed  Google Scholar 

  31. Feng Y, Hong X, Li Z, Zheng W, Jin D, Liu X et al. Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population. Obesity (Silver Spring) 2006; 14: 2089–2098.

    Article  Google Scholar 

  32. Park HS, Kim SM, Lee JS, Lee J, Han JH, Yoon DK et al. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diabetes Obes Metab 2007; 9: 50–58.

    Article  CAS  PubMed  Google Scholar 

  33. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4–12.

    CAS  PubMed  Google Scholar 

  34. Bonora E . The metabolic syndrome and cardiovascular disease. Ann Med 2006; 38: 64–80.

    Article  CAS  PubMed  Google Scholar 

  35. Tauchmanova L, Matarese G, Carella C, De Rosa G, Serio B, Ricci P et al. High serum leptin in patients with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Transplantation 2004; 78: 1376–1383.

    Article  CAS  PubMed  Google Scholar 

  36. Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfutzner A . Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 1999; 48: 677–680.

    Article  CAS  PubMed  Google Scholar 

  37. Matsubara M, Chiba H, Maruoka S, Katayose S . Elevated serum leptin concentrations in women with hyperuricemia. J Atheroscler Thromb 2002; 9: 28–34.

    Article  CAS  PubMed  Google Scholar 

  38. Hennige AM, Stefan N, Kapp K, Lehmann R, Weigert B, Beck A et al. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J 2006; 20: 1206–1208.

    Article  CAS  PubMed  Google Scholar 

  39. Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gomez-Reino J et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006; 45: 944–950.

    Article  CAS  Google Scholar 

  40. Kayacan SM, Yildiz A, Kazancioglu R, Sahin S, Sever MS, Ark E . The changes in serum leptin, body fat mass and insulin resistance after renal transplantation. Clin Transpl 2003; 17: 63–68.

    Article  Google Scholar 

  41. Zwirska-Korczala K, Zakliczynski M, Berdowska A, Zembala M, Kukla M . Serum leptin concentration in patients after heart transplantation. Clin Transpl 2006; 20: 102–105.

    Article  Google Scholar 

  42. Kapoor D, Malkin CJ, Channer KS, Jones TH . Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 2005; 63: 239–250.

    Article  CAS  Google Scholar 

  43. Kapoor D, Goodwin E, Channer KS, Jones TH . Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2005; 154: 899–906.

    Article  Google Scholar 

  44. Chen RY, Wittert GA, Andrews GR . Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab 2006; 8: 429–435.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ematologia I e Centro Trapianti di Midollo, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena IRCCS and Università degli Studi, Milan, Italy

    C Annaloro, P Usardi, A Delle Volpe & G Lambertenghi Deliliers

  2. Dipartimento di Medicina Interna, Medicina Interna I, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena IRCCS and Università degli Studi, Milan, Italy

    L Airaghi, V Giunta, A Orsatti & M Baldini

  3. Servizio di Epidemiologia, Unità Operativa di Audiologia, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena IRCCS, Milan, Italy

    S Forti

Authors
  1. C Annaloro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Usardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Airaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V Giunta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Forti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Orsatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Baldini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Delle Volpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G Lambertenghi Deliliers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Annaloro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Annaloro, C., Usardi, P., Airaghi, L. et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 41, 797–804 (2008). https://doi.org/10.1038/sj.bmt.1705972

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705972

Keywords

This article is cited by

Search

Advanced search

Quick links